Novaremed Enters Into an Exclusive Option and License Agreement With NeuroFront for the Non-opioid Neuropathic Pain Treatment, NRD.E1, for Greater China and Singapore
NeuroFront receives an exclusive option for an exclusive license to develop, commercialize and manufacture NRD.E1,…